JP2023179436A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023179436A5 JP2023179436A5 JP2023138247A JP2023138247A JP2023179436A5 JP 2023179436 A5 JP2023179436 A5 JP 2023179436A5 JP 2023138247 A JP2023138247 A JP 2023138247A JP 2023138247 A JP2023138247 A JP 2023138247A JP 2023179436 A5 JP2023179436 A5 JP 2023179436A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated protein
- seq
- protein
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17306255.5 | 2017-09-22 | ||
| EP17306255 | 2017-09-22 | ||
| JP2020516534A JP7799945B2 (ja) | 2017-09-22 | 2018-09-24 | 変異型ウイルスタンパク質 |
| PCT/EP2018/075824 WO2019057974A1 (en) | 2017-09-22 | 2018-09-24 | GLYCOPROTEIN MUTATED FROM VESICULAR STOMATITIS VIRUS |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516534A Division JP7799945B2 (ja) | 2017-09-22 | 2018-09-24 | 変異型ウイルスタンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023179436A JP2023179436A (ja) | 2023-12-19 |
| JP2023179436A5 true JP2023179436A5 (https=) | 2026-01-15 |
Family
ID=60153233
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516534A Active JP7799945B2 (ja) | 2017-09-22 | 2018-09-24 | 変異型ウイルスタンパク質 |
| JP2023138247A Pending JP2023179436A (ja) | 2017-09-22 | 2023-08-28 | 変異型ウイルスタンパク質 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516534A Active JP7799945B2 (ja) | 2017-09-22 | 2018-09-24 | 変異型ウイルスタンパク質 |
Country Status (14)
| Country | Link |
|---|---|
| US (9) | US12091434B2 (https=) |
| EP (3) | EP3684786B1 (https=) |
| JP (2) | JP7799945B2 (https=) |
| CA (1) | CA3076094A1 (https=) |
| DK (1) | DK3684786T3 (https=) |
| ES (1) | ES2991089T3 (https=) |
| FI (1) | FI3684786T3 (https=) |
| HR (1) | HRP20241466T1 (https=) |
| HU (1) | HUE069207T2 (https=) |
| LT (1) | LT3684786T (https=) |
| PL (1) | PL3684786T3 (https=) |
| PT (1) | PT3684786T (https=) |
| SI (1) | SI3684786T1 (https=) |
| WO (1) | WO2019057974A1 (https=) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2991089T3 (es) | 2017-09-22 | 2024-12-02 | Centre Nat Rech Scient | Glicoproteína mutada del virus de la estomatitis vesicular |
| EP3708176A1 (en) * | 2019-03-15 | 2020-09-16 | Centre National De La Recherche Scientifique -Cnrs- | Mutant vsv ectodomain polypeptide and uses thereof |
| US12061187B2 (en) | 2019-05-23 | 2024-08-13 | Massachusetts Institute Of Technology | Ligand discovery and gene delivery via retroviral surface display |
| US12311000B2 (en) | 2019-08-16 | 2025-05-27 | Mayo Foundation For Medical Education And Research | Chimeric vesiculoviruses and methods of use |
| CN115397838A (zh) * | 2020-01-10 | 2022-11-25 | 卡罗根公司 | 溶瘤病毒样囊泡的组合物和使用方法 |
| CN115768784A (zh) * | 2020-02-06 | 2023-03-07 | 勃林格殷格翰动物保健有限公司 | 用于检测抗弹状病毒抗体的多肽 |
| EP4182447A4 (en) * | 2020-07-14 | 2024-10-23 | Ichilov Tech Ltd. | PSEUDOTYPED VIRUSES WITH CONFIGURATION FOR EXPRESSION OF CAR IN T CELLS |
| MX2023008831A (es) | 2021-01-27 | 2023-10-19 | Umoja Biopharma Inc | Lentivirus para generar células que expresan receptores de antígeno quimérico anti-cd19. |
| CN112852757A (zh) * | 2021-02-01 | 2021-05-28 | 南京大学 | 一种制备新型溶瘤病毒EM/VSV-G Ad5sPVRCD137L的方法 |
| AU2022227021A1 (en) | 2021-02-26 | 2023-09-21 | Kelonia Therapeutics, Inc. | Lymphocyte targeted lentiviral vectors |
| JP2024513973A (ja) * | 2021-04-16 | 2024-03-27 | マサチューセッツ インスティテュート オブ テクノロジー | 造血幹細胞のウイルスによる標的化 |
| AU2022405508A1 (en) * | 2021-12-06 | 2024-05-30 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for discovery of receptor-ligand specificity by engineered cell entry |
| WO2023114884A2 (en) | 2021-12-15 | 2023-06-22 | Interius Biotherapeutics, Inc. | Pseudotyped viral particles, compositions comprising the same, and uses thereof |
| IL291148A (en) * | 2022-03-06 | 2023-10-01 | Noga Therapeutics Ltd | Lentiviral vectors for in vivo targeting of hematopoietic cells |
| US20250382586A1 (en) | 2022-05-17 | 2025-12-18 | Umoja Biopharma, Inc. | Manufacturing viral particles |
| IL317811A (en) | 2022-07-25 | 2025-02-01 | Interius Biotherapeutics Inc | Mutated polypeptides, compositions containing them and uses thereof |
| WO2024050450A1 (en) | 2022-08-31 | 2024-03-07 | Gigamune, Inc. | Engineered enveloped vectors and methods of use thereof |
| TW202434621A (zh) | 2022-11-04 | 2024-09-01 | 美商優莫佳生物製藥有限公司 | 多核苷酸構築體及相關病毒載體及方法 |
| JP2026500897A (ja) | 2022-11-04 | 2026-01-09 | ウモジャ バイオファーマ インコーポレイテッド | 融合分子を呈示するレンチウイルス粒子およびその使用 |
| WO2024097992A2 (en) | 2022-11-04 | 2024-05-10 | Umoja Biopharma, Inc. | Particles displaying adhesion-molecule fusions |
| EP4654982A1 (en) | 2023-01-27 | 2025-12-03 | Regeneron Pharmaceuticals, Inc. | Modified rhabdovirus glycoproteins and uses thereof |
| EP4680620A2 (en) * | 2023-03-17 | 2026-01-21 | Kelonia Therapeutics, Inc. | In vivo daric |
| WO2024213019A1 (zh) * | 2023-04-10 | 2024-10-17 | 深圳市济因生物科技有限公司 | 突变型vsvg及靶向载体 |
| WO2024216227A1 (en) | 2023-04-12 | 2024-10-17 | Vyriad | Cd3-redirected vectors, components thereof, and uses of the vectors and components thereof |
| WO2024238153A1 (en) | 2023-05-15 | 2024-11-21 | Umoja Biopharma, Inc. | Lentiviral delivery of anti-cd20 chimeric antigen receptors |
| WO2025006882A1 (en) * | 2023-06-30 | 2025-01-02 | The Children's Hospital Of Philadelphia | Click chemistry assisted cell surface engineering for restoring lentivirus entry |
| CN121794390A (zh) * | 2023-07-18 | 2026-04-03 | 维伟生物技术有限公司 | 纯化用树脂及其使用方法 |
| WO2025038475A1 (en) * | 2023-08-11 | 2025-02-20 | Kelonia Therapeutics, Inc. | Compositions for modifying cells |
| WO2025036498A1 (zh) * | 2023-08-16 | 2025-02-20 | 深圳市济因生物科技有限公司 | 一种病毒载体及其在感染b细胞中的应用 |
| WO2025072257A1 (en) * | 2023-09-25 | 2025-04-03 | Kelonia Therapeutics, Inc. | Compositions for treating cancer |
| AU2024353243A1 (en) | 2023-09-25 | 2026-04-09 | Kelonia Therapeutics, Inc. | Antigen binding polypeptides |
| AU2024353718A1 (en) | 2023-09-25 | 2026-04-09 | Kelonia Therapeutics, Inc. | Compositions for treating cancer |
| WO2025072615A1 (en) | 2023-09-29 | 2025-04-03 | Orbital Therapeutics, Inc. | Improved methods of making rna by splinted ligation and compositions thereof |
| WO2025102013A1 (en) | 2023-11-10 | 2025-05-15 | Vyriad | Rhabdovirus g proteins having one or more cysteine-rich regions and uses thereof |
| WO2025162379A1 (zh) * | 2024-02-01 | 2025-08-07 | 深圳市济因生物科技有限公司 | 一种多肽及包含所述多肽基因的病毒载体 |
| WO2025189142A1 (en) | 2024-03-08 | 2025-09-12 | Vyriad | Membraned vesicles and purification methods thereof |
| WO2025212851A2 (en) | 2024-04-03 | 2025-10-09 | Orbital Therapeutics, Inc. | mRNA COMPOSITIONS AND USES THEREOF IN VARICELLA ZOSTER VIRUS VACCINES |
| WO2025231174A1 (en) | 2024-04-30 | 2025-11-06 | Umoja Biopharma, Inc. | Manufacturing viral particles |
| WO2025231185A1 (en) | 2024-05-01 | 2025-11-06 | Legend Biotech Ireland Limited | Viral glycoprotein variants and uses thereof |
| WO2025235604A1 (en) | 2024-05-08 | 2025-11-13 | Umoja Biopharma, Inc. | Fusion protein for use as immune cell engager |
| WO2025247369A1 (zh) * | 2024-05-31 | 2025-12-04 | 普米斯生物技术(苏州)有限公司 | 突变的水泡病毒包膜蛋白及其在慢病毒载体包装中的应用 |
| WO2025259931A1 (en) | 2024-06-14 | 2025-12-18 | Orbital Therapeutics, Inc. | Compositions and methods for rna circularization |
| WO2025260074A1 (en) | 2024-06-14 | 2025-12-18 | Vyriad | Multiplexing functional polypeptides and recombinant rhabdoviral g glycoproteins on enveloped delivery vehicles |
| WO2026006203A2 (en) | 2024-06-24 | 2026-01-02 | Orbital Therapeutics, Inc. | Compositions and methods for making circular rna |
| WO2026006687A1 (en) | 2024-06-28 | 2026-01-02 | Orbital Therapeutics, Inc. | Circular rna compositions and uses thereof for diseases caused by varicella-zoster virus |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ517573A (en) * | 1999-09-17 | 2004-02-27 | Pro Virus Inc | Sequences of the oncolytic virus strain vesicular stromatitis virus (VSV) |
| AU2003244515A1 (en) | 2002-02-07 | 2003-09-02 | Novozymes Delta Limited | Albumin-fused anti-angiogenesis peptides |
| JP4411523B2 (ja) | 2004-03-04 | 2010-02-10 | 株式会社日健総本社 | 抗ウイルス剤 |
| US8008268B2 (en) * | 2006-07-25 | 2011-08-30 | Merial Limited | Vaccines against vesicular stomatitis |
| PL2020444T3 (pl) | 2007-08-03 | 2017-10-31 | Pasteur Institut | Wadliwe nieintegrujące lentiwirusowe wektory przenoszące dla szczepionek |
| ES2708856T3 (es) | 2007-08-03 | 2019-04-11 | Pasteur Institut | Vectores de transferencia de gen lentivírico y sus aplicaciones medicinales |
| US9296790B2 (en) | 2008-10-03 | 2016-03-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods and compositions for protein delivery |
| EP2931880B1 (en) | 2012-12-12 | 2019-03-20 | Turnstone Limited Partnership | Compositions and methods for the treatment of brain cancers |
| ES2991089T3 (es) * | 2017-09-22 | 2024-12-02 | Centre Nat Rech Scient | Glicoproteína mutada del virus de la estomatitis vesicular |
-
2018
- 2018-09-24 ES ES18773448T patent/ES2991089T3/es active Active
- 2018-09-24 EP EP18773448.8A patent/EP3684786B1/en active Active
- 2018-09-24 PL PL18773448.8T patent/PL3684786T3/pl unknown
- 2018-09-24 SI SI201831168T patent/SI3684786T1/sl unknown
- 2018-09-24 DK DK18773448.8T patent/DK3684786T3/da active
- 2018-09-24 WO PCT/EP2018/075824 patent/WO2019057974A1/en not_active Ceased
- 2018-09-24 HU HUE18773448A patent/HUE069207T2/hu unknown
- 2018-09-24 PT PT187734488T patent/PT3684786T/pt unknown
- 2018-09-24 CA CA3076094A patent/CA3076094A1/en active Pending
- 2018-09-24 US US16/649,271 patent/US12091434B2/en active Active
- 2018-09-24 EP EP24192413.3A patent/EP4442816A3/en active Pending
- 2018-09-24 EP EP24192417.4A patent/EP4446337A3/en active Pending
- 2018-09-24 LT LTEPPCT/EP2018/075824T patent/LT3684786T/lt unknown
- 2018-09-24 HR HRP20241466TT patent/HRP20241466T1/hr unknown
- 2018-09-24 JP JP2020516534A patent/JP7799945B2/ja active Active
- 2018-09-24 FI FIEP18773448.8T patent/FI3684786T3/fi active
-
2023
- 2023-08-28 JP JP2023138247A patent/JP2023179436A/ja active Pending
- 2023-09-25 US US18/473,720 patent/US12030915B2/en active Active
-
2024
- 2024-04-08 US US18/629,466 patent/US12297237B2/en active Active
- 2024-04-08 US US18/629,504 patent/US12264180B2/en active Active
- 2024-04-08 US US18/629,097 patent/US12269848B2/en active Active
- 2024-04-08 US US18/629,579 patent/US12291551B2/en active Active
-
2025
- 2025-02-14 US US19/053,808 patent/US12410216B2/en active Active
- 2025-02-14 US US19/053,784 patent/US12410215B2/en active Active
- 2025-09-05 US US19/320,938 patent/US20260078150A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023179436A5 (https=) | ||
| AU2008296733B2 (en) | VEGFR-1/NRP-1 targeting peptides | |
| JP4925540B2 (ja) | ５−ヘリックスタンパク質 | |
| JP2021520818A5 (https=) | ||
| CA2299677A1 (en) | Preparation and use of recombinant influenza a virus m2 constructs and vaccines | |
| WO2021198706A3 (en) | Coronavirus vaccines | |
| Borghouts et al. | Peptide aptamers: recent developments for cancer therapy | |
| EP4086275A1 (en) | Multimerization delivery system for intracellular delivery of molecule | |
| NZ521564A (en) | Compositions for drug delivery | |
| JP4596391B2 (ja) | 細胞透過性ペプチド | |
| WO2009155789A1 (zh) | 抑制hiv感染的多肽及其衍生物 | |
| JPWO2023039424A5 (https=) | ||
| Choi et al. | Construction and characterization of cell-penetrating peptide-fused fibroblast growth factor and vascular endothelial growth factor for an enhanced percutaneous delivery system | |
| US20090155853A1 (en) | Non-viral gene delivery complex | |
| KR101444199B1 (ko) | 세포막 투과용 단백질 및 그 용도 | |
| Yang et al. | The structure and configuration changes of multifunctional peptide vectors enhance gene delivery efficiency | |
| JP2011521648A5 (https=) | ||
| WO2011110049A1 (zh) | 抗hiv的融合多肽及其用途 | |
| WO2023215699A1 (en) | Multivalent display on enveloped particles with human oligomerization domains | |
| Yuan et al. | Novel branched amphiphilic peptides for nucleic acids delivery | |
| JP2007514429A (ja) | 細胞表面に連結され得る物質を連結するためのアダプター | |
| KR20170033559A (ko) | 유전자 전달을 위한 신규의 융합 펩타이드 | |
| CN120248078B (zh) | 一种基于arc蛋白的修饰多肽及其作为核酸递送载体的应用 | |
| WO2013165262A1 (en) | Peptides, constructs and uses therefor | |
| JP2015120657A (ja) | ペプチド及びヒト肝細胞選択的薬物送達複合体 |